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*Dear Editor*,

 {#jdv15510-sec-0001}

Food protein‐induced enterocolitis syndrome (FPIES) is a rare non‐IgE‐mediated food allergy to protein mainly in cow milk (CM) that typically presents in early infancy. Projectile and repetitive vomiting are the main clinical symptoms after 1--4 h of trigger food ingestion. Rapid recognition and instalment of a specific diet are important to avoid serious complications in affected children (see Fig. [1](#jdv15510-fig-0001){ref-type="fig"}).[1](#jdv15510-bib-0001){ref-type="ref"} According to a multicenter Italian study[2](#jdv15510-bib-0002){ref-type="ref"} atopy as co‐morbidity is rarer than in other countries being 9% compared to a much higher frequency of 28% in Spain,[3](#jdv15510-bib-0003){ref-type="ref"} 57% in Australia[4](#jdv15510-bib-0004){ref-type="ref"} and over 70% in the USA.[5](#jdv15510-bib-0005){ref-type="ref"} To analyse this topic further, we retrospectively retrieved all clinical documents reporting FPIES, as described by Sopo *et al*.,[2](#jdv15510-bib-0002){ref-type="ref"} from 2012 to 2016 from all paediatric services in South Tyrol, a northern Italian province near the Austrian border with 524.256 inhabitants at 2016 census.

![WHO weight‐for‐age percentile table for girls with values shown for infant 4. Severe underweight is noted before recommending the amino acid based of cow milk (Neocate LCP™). Copyright WHO URL: <https://www.who.int/childgrowth/standards/cht_wfa_girls_z_0_2.pdf?ua=1>.](JDV-33-e257-g001){#jdv15510-fig-0001}

In total four cases of FPIES were diagnosed in the 5 year period and are summarized in Table [1](#jdv15510-tbl-0001){ref-type="table"}. All mothers suffered from hypogalactia and had to supplement their infants, who all were hospitalized before the age of 5 months. Diagnosis of FPIES was based on typical clinical presentation and improvement after withdrawal of the suspected trigger food and confirmed with the criteria published by Nowak *et al*., 2017.[1](#jdv15510-bib-0001){ref-type="ref"} Atopic dermatitis was finally diagnosed in three of the toddlers, and all three of them showed a significant increase of total IgE. Despite not being surprising, as patients with atopic dermatitis can present an increase of total IgE,[6](#jdv15510-bib-0006){ref-type="ref"} this was not previously reported for patients also affected with FPIES. We speculate that elevated total serum IgE could be a laboratory marker for the future development of atopic dermatitis in toddlers affected by FPIES and normal skin, because typically FPIES presents before clear clinical appearance of atopic dermatitis and on the other hand could also give a hint towards the diagnosis of FPIES in doubtful cases.

###### 

Summary of gastrointestinal symptoms, with major and minor criteria of food protein‐induced enterocolitis syndrome (FPIES) as clinical outcome and atopic diseases in affected children. The diagnosis of FPIES, according to American guidelines, requires that a patient meets the major criterion and more than three minor criteria

  Patient                                                              Patient 1                                         Patient 2                         Patient 3                                                Patient 4
  -------------------------------------------------------------------- ------------------------------------------------- --------------------------------- -------------------------------------------------------- ----------------------------------------------------------------------------
  Symptoms                                                                                                                                                                                                          
  **Major criterion according American guidelines on FPIES**                                                                                                                                                        
  Vomiting in the 1‐ to 4‐h period after ingestion (no IgE symptoms)   Present                                           Present                           Present                                                  Present
  **Minor criteria according American guidelines on FPIES**                                                                                                                                                         
  A second (or more) episode of repetitive vomiting                    Present                                           Present                           Present                                                  Present
  Extreme lethargy                                                     Present                                           n.r.                              n.r.                                                     n.r.
  Marked pallor                                                        Present                                           n.r.                              Present                                                  n.r.
  Need emergency department visit                                      Present                                           Present                           n.r.                                                     Present
  Need intravenous fluid support                                       Present                                           n.r.                              Present                                                  Present
  Diarrhoea in 24 h (\* with blood)                                    Present                                           Present                           Present                                                  Present (**\***)
  Hypotension                                                          Present                                           n.r.                              n.r.                                                     n.r.
  Hypothermia                                                          Present                                           n.r.                              n.r.                                                     n.r.
  Blood values supporting acute FPIES (Leonard & al., 2012)            Neutrophils (82.3%), thrombocytes (580.000/mmc)   n.r.                              n.r.                                                     n.r.
  Blood values supporting acute FPIES (Leonard & al., 2012)            n.r.                                              n.r.                              n.r.                                                     Anaemia (transferrin 151 mg/dL, iron 25 μg/dL), hypoalbuminemia (3.2 g/dL)
  **FPIES**                                                                                                                                                                                                         
  Interruption of breast feeding (age)                                 14 days                                           3 months                          4 months                                                 2 months
  Age at onset of FPIES                                                9 days                                            3 months and 14 days              5 months                                                 2 months, diagnosis established at 5 months and 7 days
  Positive OFC for diagnosis or exposure to alternative formulas       2 months                                                                            5 months                                                 
  Age of tolerance shown by OFC                                        20 months                                         2 years and 5 months                                                                       20 months
  Not recommended autonomous OFC at home (age)                         7 months: FPIES symptoms; 14 months: Tolerated                                      20 months: Tolerated                                     
  Family history of atopy                                              Not reported                                      Father with rhinitis and asthma   Brother with atopic dermatitis and dubious FPIES to CM   None
  Supplementation                                                      'Colecalcium' (HUMANA), Vit D and Calcium                                           'Duocal' (NUTRICIA), glucidic‐lipidic formula            'Dicoflor' (DICOFARM), probiotics with Lactobacillus GG
  **Atopy**                                                                                                                                                                                                         
  Total IgE during first FPIES reaction                                Not performed                                     38 IU/mL (normal \<13)            72 IU/mL (normal \<13)                                   54 IU/mL (normal \<13)
  Atopic eczema (age of confirmed onset)                               Not reported                                      5 months                          8 months                                                 2 months
  Positive Food Skin Prick Test/Rast Test during FPIES (food)          Not reported                                      white egg, both tests positive    Not reported                                             Casein nBos d8, light positive in Rast Test 0.4 kUA/L (\<0.35)
  IgE Food Allergy Symptoms (age of onset)                             Not reported                                      3 years                           Not reported                                             Not reported
  Anaphylaxis (age of onset)                                           Not reported                                      4 years                           Not reported                                             Not reported
  Allergic rhinoconjunctivitis with asthma (age of onset)              Not reported                                      4 years                           12 months                                                Not reported

OFC, oral food challenge.
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Making recommendations for the milk replacement can be difficult. Hydrolysed formulas of CM represent the first choice, followed, in case of intolerance, by amino acid‐based formulas (AAF). Substitutes based on other protein sources should be avoided due to correlation to FPIES described for soy and oat in America,[1](#jdv15510-bib-0001){ref-type="ref"} to rice protein in Australia[7](#jdv15510-bib-0007){ref-type="ref"} and fish in Italy.[2](#jdv15510-bib-0002){ref-type="ref"} We also found a second intolerance probably related to FPIES to rice, when patient 3 again showed symptoms of FPIES taking formulas containing rice protein.

A recent Australian population‐wide study reported an incidence of 15.4/100 000/year, so FPIES could be more frequent but underdiagnosed.[4](#jdv15510-bib-0004){ref-type="ref"} One reason for this underdiagnosis is that parents might also directly avoid feeding suspected products without seeking medical attention, as seen with the sibling of patient 3. However, as awareness increases, reported incidence rates will rise and FPIES is thought to be an emerging allergic disease.[8](#jdv15510-bib-0008){ref-type="ref"}

According to our study with three atopic toddlers of four found, the association of FPIES with atopy in Italy might well be higher than the 9% previously reported. The main reasons for this probably are that patients in our study were diagnosed by a dermatologist, while in the previous study no dermatologists were involved. Further, the previous study was older (2004--2010), so a higher awareness of the atopic association with FPIES could also have been playing a role. Awareness of atopy or atopic predisposition is important, as it has been shown that very early skin moisturizing reduces the development and severity of atopic disease. Therefore, we conclude that a dermatologic presentation with counselling to consequent skin care should be advised in all affected children at diagnosis of FPIES in order to reduce or even completely avoid burden of atopic disease.[9](#jdv15510-bib-0009){ref-type="ref"}, [10](#jdv15510-bib-0010){ref-type="ref"}
